Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 12, 2025 06:39 ET | Source: Research and Markets

Constipation Treatment - Global and Regional Markets Analysis, 2025-2030 - Increasing Demand for OTC Laxatives and Natural Remedies

Dublin, Feb. 12, 2025 (GLOBE NEWSWIRE) -- The "Constipation Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market for Constipation...
June 07, 2024 09:26 ET | Source: Research and Markets

Opioid-Induced Constipation Market Trends, Epidemiology, and Unmet Needs to 2034: 7MM Projected to Reach $1.16 Billion

Dublin, June 07, 2024 (GLOBE NEWSWIRE) -- The "Opioid-Induced Constipation Market: Epidemiology, Industry Trends, Share, Size, Growth, Opportunity, and Forecast 2024-2034" report has been added to ...
March 04, 2024 12:09 ET | Source: Research and Markets

Constipation Treatment Market Projected to Reach $27.5 Billion by 2030, as Laxatives Segment Accelerates Globally

Dublin, March 04, 2024 (GLOBE NEWSWIRE) -- The "Constipation Treatment: Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.Emerging Trends and High Growth...
February 09, 2024 09:36 ET | Source: Research and Markets

Constipation Treatment Global Market Report 2023: Growth Trajectories, Product Innovations, and Strategic Acquisitions to 2033

Dublin, Feb. 09, 2024 (GLOBE NEWSWIRE) -- The "Constipation Treatment Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering. The constipation treatment sector is...
June 14, 2019 09:00 ET | Source: Transparency Market Research

Rapid Approval of Pipeline Drugs to Augment Opioid Induced Constipation Treatment Market – TMR

Albany, New York, June 14, 2019 (GLOBE NEWSWIRE) -- Opioids are drugs, which when used in a certain proportion, work as pain killers and medicines for medical ailments, such as diarrhea and...
October 11, 2013 06:45 ET | Source: Sucampo Pharmaceuticals Inc

Sucampo Announces Presentation of Results on AMITIZA(R) (lubiprostone) in Opioid-Induced Constipation at Two Upcoming Scientific Conferences

BETHESDA, Md., Oct. 11, 2013 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Nasdaq:SCMP) ("Sucampo") today announced the presentation of three posters evaluating AMITIZA® (lubiprostone) in...